- Academic Editors
†These authors contributed equally.
The residual SYNTAX score (rSS) is employed for the quantification of residual coronary lesions and to guide revascularization. rSS can be combined with other examinations to evaluate the severity of vascular disease and play an evaluative and guiding role in various scenarios. Furthermore, combining rSS with other indicators, benefits prognosis evaluation, and rSS-derived scores have been increasingly used in clinical practice. This article reviews the progress in the clinical application of rSS and its derived scores for complex coronary arteries and other aspects, based on relevant literature.
Coronary artery disease (CAD) is a prevalent cardiovascular disorder associated with significant mortality rates [1], and complex coronary artery lesions are the focus of CAD treatment. With the popularization and improvement of percutaneous coronary intervention (PCI) technology and related device materials, PCI has increasingly become a frequent and important means of managing CAD. However, the occurrence of major adverse cardiovascular events (MACE) in certain patients undergoing PCI remains high [2]; therefore, choosing a reasonable treatment strategy for CAD is particularly important.
Sianos et al. [3] proposed the SYNTAX score (SS) in 2005, based on the SYNTAX study. SS can predict patients’ prognoses after PCI or coronary artery bypass graft (CABG) and evaluates untreated coronary vessels. Vessels after interventional treatment and untreated vessels have significant anatomical differences; notably, the operator’s surgical experience, surgical strategy, and surgical environment contribute to the differences. SS cannot effectively evaluate this difference; therefore, it cannot fully reflect the improvement of coronary vessels. With the continuous improvement of the SS system, the residual SYNTAX score (rSS) has been proposed to quantitatively measure the extent of residual coronary artery stenosis after PCI. After continuous clinical exploration, the rSS system and its application range have expanded. In addition, rSS can show different clinical values in different laboratory inspections or tests combined with non-digital subtraction angiography (non-DSA) and can be employed for the assessment of the prognosis pertaining to non-coronary artery lesions. Notably, rSS has some limitations. With the deepening of clinical research and the enrichment of examination methods, more rSS-derived scores have been discovered and applied in clinical practice. This article summarizes and reviews the clinical application of rSS and its derived scores to optimally utilize them as a series of important tools (Fig. 1).
Mind map of residual SYNTAX score (rSS) and its derived scores.
The ideal goal of PCI is complete revascularization (CR) of all diseased segments. The significance of CR in predicting outcomes and incomplete revascularization (ICR) varies in different studies, possibly because of the absence of a widely acknowledged definition, variations in statistical and methodological approaches, and variations in study populations; as a result, different studies have conflicting results [4]. The anatomically accepted definition of ICR is the presence of at least one vessel larger than 2.0 mm in diameter with a minimum of at least one lesion in the coronoary artery after PCI exhibiting stenosis exceeding 50% (the standard for CABG treatment is 1.5 mm). There is a premise indicating that regardless of the location, complexity, or clinical background of the vascular lesion, ICR is defined as any lesion that has not been treated. Although CR can broadly improve myocardial ischemia and prevent unplanned revascularization, the overaggressive treatment of CR may lead to restenosis within the stent [5] and thrombosis of the stent [6], thus increasing the likelihood of complications during the perioperative period [7]. CR is frequently impractical to implement in individuals with multivessel CAD for various causes, including chronic total occlusion (CTO), severe calcification, significant impairment of the left ventricle’s function, or poor medical condition. PCI in individuals with lesions of greater complexity may lead to a rise in procedure-related adverse events. CR is not easily achieved in medical practice and may not improve the prognosis of patients; therefore, indiscriminately pursuing CR is needless. Reasonable revascularization is of great significance in guiding clinical decision-making.
SS is a commonly used tool for coronary artery assessment in clinical practice.
SS can quantitatively evaluate the location, degree, and nature of coronary
artery lesions according to their anatomical structure and can effectively and
precisely assess their complexity and progression (Fig. 2) [3]. However, the
application of SS cannot fully reflect the improvement of coronary artery lesions
after PCI [8]. To solve this problem, rSS was developed after the Acute
Catheterization and Urgent Intervention Triage Strategy (ACUITY) study [9]. rSS,
defined as the residual SYNTAX score after PCI or CABG, is a score for lesions
with
Distribution of coronary arteries in the heart according to SYNTAX score (SS). The numbers in the figure represent the segments divided by SS and correspond to the following definition of segments: 1: RCA proximal; 2: RCA mid; 3: RCA distal; 4: Posterior descending artery; 5: Left main; 6: LAD proximal; 7: LAD mid; 8: LAD apical; 9: First diagonal; 9a: Additional first diagonal originating from segment 6 or 7, before segment 8; 10: Second diagonal; 10a: Additional second diagonal originating from segment 8; 11: Proximal circumflex artery; 12: Intermediate/ anterolateral artery; 12a: First side branch of circumflex running in general to the area of obtuse margin of the heart; 12b: Second additional branch of circumflex running in the same direction as 12; 13: Distal circumflex artery; 14: Left posterolateral; 14a: Distal from 14 and running in the same direction; 14b: Distal from 14 and 14 a and running in the same direction; 15: Posterior descending; 16: Posterolateral branch from RCA; 16a: First posterolateral branch from segment 16; 16b: Second posterolateral branch from segment 16; 16c: Third posterolateral branch from segment 16. The calculation of SS can be done at this latest website: https://syntaxscore.org/. SS, SYNTAX score; LAD, left anterior descending; RCA, right coronary artery.
In a retrospective study on CTO and multivessel CAD in patients after PCI, Jang
et al. [12] discovered that the cardiac mortality of patients with rSS
SRI, first proposed by Généreux et al. [16], was calculated as
the ratio of the difference between the baseline SS (bSS) and rSS to the bSS (SRI
= (bSS-rSS)/bSS
The limited inclusion of clinical parameters in the rSS poses a challenge to its
effectiveness in accurately stratifying the risk of patients with complex CAD.
rSS is a scoring system for angiography; CRSS is obtained by integrating clinical
variables with rSS. CRSS is calculated by multiplying rSS by the modified age,
creatinine, and ejection fraction score, i.e., the “modified age, creatinine, and ejection fraction (ACEF)”
score [19]. Studies have shown that CRSS better predicts 1-year
all-cause mortality and target lesion failure (TLF) rates in comparison to rSS
alone, and patients with CRSS
Focusing solely on anatomical factors overlooks individual differences caused by clinical factors, leading to false risk stratification. The SYNTAX II score (SS-II) is obtained by assessing clinical features which improve the ability to predict risk and combining them with SS to assess and compare long-term mortality between PCI and CABG strategies. Variables in the SS-II include peripheral arterial disease (PAD), chronic obstructive pulmonary disease (COPD), left main (LM) disease, left ventricular ejection fraction (LVEF), estimated glomerular filtration rate (eGFR) sex, and age [22]. A multi-ethnic minority cohort study has shown that additional modifications for other variables and comorbidities did not change the association’s magnitude in the SS-II score, suggesting that the comorbidities included in the scoring system are the most important [23]. Furthermore, when combined with clinical variables, rSS-II has a richer set of variables compared with CRSS, as it combines several clinical comorbidities closely related to prognosis, all of which are nearly irreplaceable. While certain factors in SS-II (age, sex, PAD, and COPD) remain the same after revascularization, other variables, such as CRCL, LVEF, anatomical SS, and unprotected LM stenosis, may improve or worsen after PCI. A prospective, multicenter cohort study showed that combining SS-II and rSS could help identify the increased risk of long-term clinical adverse events in patients with acute coronary syndrome (ACS) and multivessel disease (MVD). In Cox regression analysis, rSS-II exhibited a correlation with mortality from all causes during a 5-year follow-up period and better stratified the risk of all-cause mortality and MACE than rSS [24]. In a study [23] of patients with three-vessel or LM disease who underwent initial PCI for ST-segment elevation MI (STEMI) during long-term follow-up (mean: 4.9 years), higher rSS-II scores were linked to a higher likelihood of mortality and readmission. This study supports the utility of rSS-II to guide the risk stratification and revascularization strategy selection in STEMI patients with LM disease or MVD.
Previous studies have shown that the revascularization of diseased segments only
with a diameter
The anatomic lesion severity was inconsistent with the functional significance
based on FFR [27, 30, 31]. FFR is considered the “gold standard” for
functionally assessing the severity of ischemia caused by coronary artery
stenosis and guiding revascularization procedures (Fig. 3). An FFR-guided
revascularization strategy is more rational than angiography-guided
revascularization or medical therapy [32, 33]; once functional CR (FCR) is
achieved, the results are likely to be similar, regardless of the anatomy of the
residual disease [34]. Previously, Nam et al. [35] developed the
functional SYNTAX score (FSS) concept by integrating SS and FFR; they calculated
SS only in vessels with low FFR (FFR
Real-time recording of fractional flow reserve (FFR). In the selected segment of the occluded vessel, Pd and Pa are the distal and proximal blood pressure values of the vesse, and FFR is equal to PD divided by PA. Pd is the aortic pressure measured by the guide catheter and Pa is the distal pressure measured by the pressure guide wire. FFR, fractional flow reserve.
rFSS is the cumulative sum of residual scores for vessels exhibiting low FFR
(FFR
Although FFR is the gold standard for coronary physiological assessments, its
utilization is significantly less extensive than expected, possibly due to the
cost of pressure guidewires, additional procedures, prolonged procedural times,
and side effects caused by adenosine. To overcome these real-world clinical
limitations and further expand the practical scope of physiological lesion
assessments, wire-free QFR based on coronary angiography was developed as a new
tool for coronary physiological assessment. QFR is a reliable and rapid method to
calculate functional parameters based on three-dimensional quantitative coronary
angiography to detect hemodynamically significant lesions. The pressure curve is
simulated from the angiography images by computer software, and the value of QFR
is calculated according to the pressure difference between the two ends of the
selected lumen (Fig. 4). Compared with FFR, QFR calculated only based on imaging
has the advantages of not using hyperemia-inducing drugs and pressure guidewires,
short operation times, and specific clinical diagnostic accuracy. The FAVOR pilot
[40] study showed that QFR and FFR measurement results are consistent; the FAVOR
II China [41] study was the first to reveal the diagnostic accuracy of real-time
online QFR analysis in the catheterization laboratory. With FFR as the reference
standard, the final QFR diagnostic accuracy was 92.7%, consistent with the FAVOR
II Europe-Japan study [42]. Furthermore, the latter suggested that QFR could
reduce the procedure time by 28% compared with FFR. These studies show that QFR
technology is practical and reliable in clinical practice. Tang et al.
[43] combined QFR with rSS and discarded smaller vessels (
Quantitative flow ratio (QFR) analysis based on coronary angiography. (a) After QFR analysis, the gray part is the recommended placement of the virtual stent. (b) The QFR at the location of the vessel intercepted by the white vertical line is 0.61. PN and DN are the two normal points of the selected blood vessels as reference points. When the white tangential line of the blood vessel selected in (a) continues to move to the distal end of the blood vessel, the white vertical line in (b) continues to move to the right and the QFR of the selected blood vessel will be analyzed in real time. B1–B7 are small branches from LM to LAD. QFR, quantitative flow ratio; DN, distal normal; LM, left main; LAD, left anterior descending; PN, proximal normal.
In the study by Lee et al. [44], patients who attained FCR as determined by rFSS experienced a notable improvement in exercise duration following PCI, in contrast to patients with incomplete or partial FIR, similar to the results obtained by Xue et al. [45] using rSS; this study compared patients’ exercise time, while Xue et al. [45] compared cardiopulmonary exercise testing (CPET) variables. However, the study by Lee et al. [44] showed that an increased exercise time correlated more strongly with rFSS than with rSS, a drop in SS, or an increase in three-vessel QFR. Among the parameters of post-PCI anatomical or functional outcomes, rFSS is superior in predicting the post-PCI exercise capacity or clinical outcome.
The FAVOR III China Trial [46] was a prospective, multicenter, blinded,
randomized clinical trial of 3830 patients divided into QFR- and coronary
angiography-guided groups on a 1:1 basis. PCI was performed for 50–90% stenosis
of arterial diameters
Zhang et al. [48] conducted noninvasive examinations, including
exercise ECG and CCTA, combined with rSS separately for a retrospective study. As
the limitations of FFR have been described previously, the computational
pressure-flow dynamics-derived FFR (caFFR) was used as the reference standard
instead of invasive FFR (Fig. 5). Patients older than 60 years of age were
enrolled and divided into caFFR-positive (
Functional analysis of coronary computed tomography angiography (CCTA). (a–d) The four images represent the functional analysis of different parts of the coronary artery. (a) and (b) analyze the different branches of the left anterior descending. The FFR obtained by the three vessels is as follows: LAD: 0.48 (a) and 0.43 (b) ; LCX: 0.88 (c); RCA: 0.90 (d) . LAD, left anterior descendin; LCX, left circumflex (branch); RCA, right coronary artery; CCTA, coronary computed tomography angiography; FFR, fractional flow reserve.
Wang et al. [53] studied the prognostic impact of rSS and the culprit
plaque morphology on MACE in 274 patients with STEMI. The study was divided into
two aspects, and patients were divided into four groups based on rSS and plaque
morphology, including plaque rupture (PR)/high rSS, PR/low rSS, plaque erosion
(PE)/high rSS, and PE/low rSS. Patients’ plaques were analyzed by OCT, and
patients were divided into four groups (according to high-risk plaques (HRP),
defined by OCT [54] combined with rSS), including HRP/high rSS, HRP/high rSS,
non-HRP/high rSS, and non-HRP/low rSS. The study showed that patients with
PR/high rSS had a higher risk of plaques and a 4.80-fold higher risk of
cardiovascular events than those with PE/low rSS; however, patients with HRP/high
rSS had a higher risk of MACE. Furthermore, the author stated in another article
[55] that patients with higher rSS (rSS
In addition, Fujino et al. [56], in the Providing Regional Observations
to Study Predictors of Events in the Coronary Tree (PROSPECT) study [57],
assessed the plaque morphology by greyscale IVUS and virtual histology IVUS
(VH-IVUS) and discovered an association with rSS. The results suggest that the
presence of
The application of SPECT enables the prediction of adverse cardiac events in
patients with CAD [58]. The difference in the percentage of the total myocardium
Safety Data Sheet (SDS%) between the first and second SPECT—
Patients with CAD have a higher likelihood of experiencing complications with CKD, and patients with CKD face a significant risk factor of cardiovascular disease [60]. Once patients with cardiovascular disease are complicated with CKD, they may have more complex anatomical problems such as calcification, bifurcations, long lesions, and multi-vascular diseases, which will increase the related complications of surgery, reduce the success rate of surgery, and lead to higher mortality [61]. In addition, patients with CKD are more likely to develop CIN after PCI [62]; therefore, ICR treatment may be more appropriate for patients with complex CKD undergoing PCI to reduce the potential surgical risk.
Yan et al. [63] used rSS as a quantitative tool to evaluate the degree
of ICR in patients with CKD. In this study, subjects were divided into the CR
group (rSS = 0), R-ICR group (0
Cardi et al. [64] have shown that patients with CKD have higher rSS
values; studies have found that patients with rSS
Xue et al. [45] conducted a retrospective study to quantify ICR indexes
by rSS and evaluated the impact of ICR on exercise tolerance. A total of 87
patients underwent CPET within a year following PCI; CPET variables were
collected and compared. According to the rSS, the patients were divided into the
CR (rSS = 0), R-ICR (0
CAD exists in more than half of the population with TAVR [67, 68]. Early trials
reported no association between CAD and increased mortality after TAVR [69, 70];
however, later trials used SS to stratify the CAD severity, resulting in
conflicting conclusions [71]. Witberg et al. [72] reviewed six studies
using rSS to define R-ICR and ICR thresholds in 3107 patients and conducted a
meta-analysis of the prognosis of TAVR with a follow-up period of 0.7–3 years.
The results showed that patients with CAD who had R-ICR (0
Notably, a subsequent study [75] did not show an association between CAD and the degree of revascularization after TAVR, during long-term follow-up. Therefore, Scarsini et al. [76] considered the anatomy alone and in combination with the function and proved that incomplete functional revascularization was associated with poor clinical outcomes after TAVR through rFSS, a derivative of rSS. However, the sample size in the study was limited, and further studies are needed for confirmation.
DAPT with a P2Y12-receptor inhibitor plus aspirin is essential for preventing
coronary stent thrombosis. The prospective, multicenter ILOVE-IT2 trial
[77], in which all patients continued to take a minimum of 75 mg of clopidogrel
and 100 mg of aspirin for 6 or 12 months after stent implantation, was
investigated for composite clinical endpoints. A secondary analysis of this trial
showed that in the low rSS group (rSS = 0), patients who used DAPT for 6 months
after PCI were not inferior to the subgroup that continued DAPT for 12 months. In
contrast, patients at higher risk after PCI (rSS
The CHA2DS2-VASc score is used to evaluate patients with cardiovascular disease
[80] and atrial fibrillation to assess the risk of thromboembolism [81] and is
increasingly widely used in various scenarios. The coronary thrombotic state is
related to the extent of stenosis in coronary arteries, and research has
indicated that this score can predict adverse events after ACS [82]. In a novel
study [83] involving 688 STEMI patients after PCI, a positive correlation between
the rSS and CHA2DS2-VASc score was confirmed for the first time, and the
CHA2DS2-VASc score exhibited a strong ability to forecast elevated rSS (rSS
Type 2 diabetes mellitus (T2DM) is an important contributing factor to the
development of CAD. The TyG index is derived from the product of fasting blood
glucose and triglyceride levels and can be employed for evaluating the risk of
cardiovascular disease [84]. In previous studies [85, 86, 87], the TyG index has
shown a strong predictive power for the post-PCI risk in different cohorts;
however, none combined the TyG index with rSS. Xiong et al. [88]
investigated the prognostic value of adverse cardiac consequences in T2DM
patients after PCI and the possible added predictive significance of combining
rSS with the TyG index. The results showed poor outcomes after PCI were more
prevalent in patients with T2DM with rSS
Inflammation has a crucial function in the pathophysiology of CAD. Factors such as the vascular damage caused by increased neutrophil activity, activation of coagulation pathways, microvascular obstruction (caused by platelet aggregation), and myocardial cell necrosis (caused by proinflammatory cytokine secretion), lead to an increased risk of thrombosis and plaque rupture [89]. In addition, neutrophils have connections to escalate blood viscosity, hypercoagulability, and the induction of microvascular and reperfusion injury [90]. Furthermore, the cortisol secretion induced by the stress associated with ACS leads to increased lymphocyte apoptosis, and the inflammatory response induces lymphopenia. NLR serves as a predictive factor linked to the inflammatory condition of CAD. It has demonstrated superior predictive capability compared to neutrophil or lymphocyte counts and exhibited independent prognostic value for high rSS in 613 patients with STEMI. It has shown to be a better prognostic factor than the neutrophil or lymphocyte count and was an independent predictor of high rSS in 613 patients with STEMI [91]. Notably, this study suggests that diabetes is closely related to increased inflammation, and diabetic patients have higher NLR, which is a potential risk of high rSS. In addition, NLR is positively associated with age, which can lead to an increased coronary burden. LVEF-related coronary atherosclerosis may lead to systemic inflammation, resulting in a higher NLR and adversely affecting the blood vessels; LVEF is negatively correlated with NLR. These factors can affect residual CAD and increase the risk of ischemic occurrences.
White blood cells play a crucial role in the progression of atherosclerosis and
instability, and have the potential to result in thrombotic occurrences. An
increased white blood cell count (WBC) has been linked to higher mortality rates
in patients with STEMI. The mean platelet volume (MPV) serves as an extremely
responsive indicator for platelet activity, and larger platelets have higher
thrombotic potential. The changes in MPV and WBC levels caused by increased
inflammation and thrombosis could elucidate the elevated WMR levels in patients
with ACS. The advantage of WMR is that it is performed at no additional cost in
high-risk clinical situations such as STEMI. However, its ability to accurately
assess risk and its potential for enhancing clinical risk categorization and
treatment strategizing makes it an excellent tool. WMR is more efficient than
other whole blood cell indices in predicting long-term MACE in patients with
NSTEMI. Patients with high WMR (
After over 10 years of development, rSS is increasingly used in clinical practice. It is suitable for evaluating complex vascular diseases and can be combined with various clinical tools to predict the prognosis of patients and guide treatment. However, when performing rSS-related calculations, especially the calculation of the corresponding weights of each blood vessel of the patient, the help of calculation tools or websites is required or the weight table is consulted for manual calculation, unless that person is an expert in this field. In addition, some hospitals in the real world, especially primary hospitals, may focus mainly on solving the difficulties encountered on the operating table and the immediate effect of the operation, rather than paying more attention to how to improve the long-term prognosis, so the popularity of this score is limited. One solution is that the rSS-related calculation can be directly implanted into the angiography imaging device through the designed script, and the artificial intelligence can automatically and objectively analyze each blood vessel diameter and blood vessel condition and calculate the corresponding score immediately, or even can be directly implanted into the instrument to calculate QFR, and directly obtain the rSS-related score with or without function.
Compared with rSS, the derived scores have advantages suitable for various clinical settings. Compared with the standard anatomical assessment of coronary angiography, QFR technology has a superior specificity and sensitivity and is more efficient and safer than traditional FFR. In addition, it has clinical benefits after achieving FCR. Due to these advantages, QFR may become an essential tool for interventional therapy; however, the available evidence for the use of QFR in evidence-based medicine is still relatively limited. With the advancement of various clinical studies, the role of QFR may become increasingly important, and QFR-based rFSS has broad application prospects.
However, there are still some limitations with Q-rFSS. First, although the scoring system includes a weighting factor for each lesion to distinguish the anatomical importance differences of each lesion, previous studies have suggested that atherosclerosis progresses faster in the proximal left anterior descending (pLAD) than in other segments [93], and pLAD coronary artery lesions possess greater predictive significance [94]. Futhermore, a study [95] has shown that rSS combined with residual pLAD outperforms rSS alone in predictive performance; therefore, a higher score weight may be required for pLAD coronary artery stenosis. Second, Q-rFSS only includes anatomical and functional evaluations and does not include clinical factors. Whether adding clinical factors, such as rSS-II, can improve the discriminative power of clinical results remains unclear. In addition, relevant studies have not confirmed whether including certain laboratory tests or auxiliary scores (as mentioned above) related to Q-rFSS can increase the predictive accuracy. Therefore, rSS and its derived scores can be developed and improved to be extensively used in various clinical scenarios.
3V-FFR-FRIENDS, three-vessel fractional flow reserve for the assessment of total stenosis burden and its clinical impact in patients with coronary artery disease; ACEF, age, creatinine, and ejection fraction; ACS, acute coronary syndrome; ACUITY, Acute Catheterization and Urgent Intervention Triage Strategy; bSS, baseline SYNTAX score; CABG, coronary artery bypass graft; CAD, coronary artery disease; caFFR, computational pressure-flow dynamics-derived fractional flow reserve; CCTA, coronary computed tomography angiography; CIN, contrast-induced nephropathy; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CPET, cardiopulmonary exercise testing; CR, complete revascularization; CRCL, creatinine clearance; CRSS, clinical residual SYNTAX score; CTO, chronic total occlusion; DAPT, dual antiplatelet therapy; DSA, digital subtraction angiography; ECG, electrocardiogram; eGFR, estimated glomerular filtration rate; FCR, functional complete revascularization; FIR, functional IR; FFR, fractional flow reserve; FSS, functional SYNTAX score; HRP, high-risk plaques; ICR, incomplete revascularization; IVUS, intravascular ultrasound; LM, left main; LVEF, left ventricular ejection fraction; MACE, major adverse cardiovascular event; MI, myocardial infarction; MPV, mean platelet volume; mrSS, modified residual SYNTAX score; MVD, multivessel disease; NACE, net adverse clinical events; NLR, neutrophil to lymphocyte ratio; NSTEMI, non-ST-segment elevation myocardial infarction; OCT, optical coherence tomography; PAD, peripheral artery disease; PCI, percutaneous coronary intervention; PE, plaque erosion; pLAD, proximal left anterior descending; PoCE, patient-oriented composite endpoint; POCE, patient-oriented composite events; PR, plaque rupture; PROPSPECT, Providing Regional Observations to Study Predictors of Events in the Coronary Tree; QFR, quantitative flow ratio; Q-rFSS, QFR-guided residual functional SYNTAX score; rFSS, residual functional SYNTAX score; R-ICR, reasonable incomplete revascularization; ROC, receiver operating characteristic; rSS, residual SYNTAX score; rSS-II, residual SYNTAX score-II; SDS%, percentage of the total myocardium Safety Data Sheet; SICR, severe incomplete revascularization; SPECT, single-photon-emission computed tomography; SRI, SYNTAX revascularization index; SS, SYNTAX score; SS-II, SYNTAX score-II; STEMI, ST-segment elevation myocardial infarction; T2DM, type 2 diabetes mellitus; TAVR, transcatheter aortic valve replacement; TLF, target lesion failure; TVF, target vessel failure; TyG, triglyceride-glucose; UR, unplanned revascularization; VH-IVUS, virtual histology intravascular ultrasound; VH-TCFA, virtual histology thin-cap fibroatheroma; WBC, white blood cell count; WMR, white blood cell count to mean platelet volume ratio.
XJL drafted the manuscript; XJL, CXX, ZBM, WJ and YGW contributed to conception and design. CXX and YGW are mainly responsible for reviewing and revising the article. All authors contributed to editorial changes in the manuscript. All authors read and approved the final manuscript. All authors have participated sufficiently in the work and agreed to be accountable for all aspects of the work.
Not applicable.
Not applicable.
This research received no external funding.
The authors declare no conflict of interest.
Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.